SCHEMBL31235913

SCHEMBL31235913

Brc1ccc2c(c1)OC1(CC2)CNC1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 3/20 0.40
▸ PNMT P11086 1/20 0.39
▸ ASIC3 Q9UHC3 1/20 0.39
▸ KDM1A O60341 1/20 0.38
▸ AHR P35869 4/20 0.34
▸ HTR2A P28223 2/20 0.34
▸ CMA1 P23946 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ DRD2 P14416 1/20 0.33
▸ BACE1 P56817 3/20 0.33
▸ TDP2 O95551 1/20 0.33
▸ PARP1 P09874 1/20 0.33
▸ PARP10 Q53GL7 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ BLM P54132 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31236087 0.85 HTR2C (0.49) HTR2CPNMTASIC3KDM1AAHR
SCHEMBL29790967 0.83 KDM1A (0.40) HTR2CPNMTASIC3KDM1AAHR
SCHEMBL29790928 0.81 KDM1A (0.39) HTR2CPNMTASIC3KDM1AAHR
SCHEMBL30017128 0.80 LMNA (0.43) HTR2CPNMTASIC3KDM1AAHR
SCHEMBL31543860 0.80 HSD11B1 (0.46) HTR2CKDM1AAHRHTR2ACMA1
SCHEMBL11248582 0.80 HTR2C (0.43) HTR2CPNMTASIC3AHRHTR2A
SCHEMBL15075057 0.76 MALT1 (0.46) HTR2CKDM1AAHRBACE1MAPT
SCHEMBL25337824 0.75 HTR2C (0.49) HTR2CPNMTASIC3AHRHTR2A
SCHEMBL23928891 0.75 SIGMAR1 (0.50) HTR2CKDM1AHTR2ADRD2
SCHEMBL5321592 0.72 HTR2C (0.46) HTR2CPNMTASIC3KDM1AAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4722219-A1 CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION Gan & Lee Pharmaceuticals Co., Ltd. (CN) 2026-04-08 — — EP disclosed
WO-2025098503-A1 CEREBLON E3 UBIQUITIN LIGASE INHIBITOR 甘李药业股份有限公司 2025-05-15 — — WO disclosed
WO-2024240268-A1 CEREBELLAR PROTEIN E3 UBIQUITIN LIGASE INHIBITOR AND CHIMERIC COMPOUND TARGETING PROTEIN DEGRADATION 甘李药业股份有限公司 2024-11-28 — — WO disclosed
Send feedback